WhiteOak Capital Pharma and Heathcare Fund is an average performer in its category with a BullWiser Honest Score of 7.0/10 — above the Equity Scheme - Sectoral/ Thematic category median of 5.2/10 across 255 funds. Its 3-year CAGR of 15.9% outperforms the Equity Scheme - Sectoral/ Thematic category average of 11.4% by +4.5 percentage points. As a Direct plan, WhiteOak Capital Pharma and Heathcare Fund eliminates the distributor commission built into Regular plans, maximising the net return to the investor.
Fund Details
Fund Name
WhiteOak Capital Pharma and Heathcare Fund
Plan Type
Direct · Growth
Expense Ratio
--
Verdict
🟡 Average
1Y Return
18.3%
3Y CAGR
15.9%
vs Category Average — Equity Scheme - Sectoral/ Thematic
3Y CAGR
This fund+4.5% vs category avg
Expense Ratio (lower is better)
TER data not available
Honest Score
This fund+1.8 vs category avg
Category: Equity Scheme - Sectoral/ Thematic · 255 Direct-plan funds compared · 1% are High Quality
Frequently Asked Questions
What is the BullWiser Honest Score of WhiteOak Capital Pharma and Heathcare Fund?
WhiteOak Capital Pharma and Heathcare Fund has a BullWiser Honest Score of 7.0/10 (AVERAGE).
The score rates the fund across four pillars: returns quality, expense ratio, risk-adjusted performance (Sharpe ratio & max drawdown), and overall fund quality (AUM, age, consistency).
What is the expense ratio of WhiteOak Capital Pharma and Heathcare Fund?
The Total Expense Ratio (TER) of WhiteOak Capital Pharma and Heathcare Fund Direct Plan is --.
Choosing the Direct plan saves you the distributor commission baked into Regular plans — typically 0.5–1% per year — which compounds significantly over time.
What are the returns of WhiteOak Capital Pharma and Heathcare Fund?
WhiteOak Capital Pharma and Heathcare Fund has delivered 18.3% 1-year returns and
15.9% 3-year CAGR. For a full NAV history and comparison with category peers,
use BullWiser's MF Analyser.
Past performance is not a guarantee of future returns.
Is WhiteOak Capital Pharma and Heathcare Fund a good investment?
BullWiser rates WhiteOak Capital Pharma and Heathcare Fund as AVERAGE (Honest Score 7.0/10).
Always match a fund to your own risk profile and investment horizon.
Use the MF Analyser to compare it with peers in the Equity Scheme - Sectoral/ Thematic category.
How does Direct Plan differ from Regular Plan for WhiteOak Capital Pharma and Heathcare Fund?
The Direct plan of WhiteOak Capital Pharma and Heathcare Fund has a lower expense ratio than the Regular plan because no distributor commission is paid.
On a ₹10 lakh investment over 20 years, even a 0.5% lower TER can save ₹5–10 lakh in compounded wealth.
BullWiser always recommends Direct plans for cost-conscious investors.
See Full Analysis on BullWiser
NAV chart, holdings, Direct vs Regular savings, Sharpe ratio, and personalised comparison — all free.
Open in MF Analyser →Browse Equity Scheme - Sectoral/ Thematic Funds
⚠️ Disclaimer: BullWiser is an independent analysis platform, not a SEBI-registered investment advisor.
Honest Scores and verdicts are algorithmic assessments based on publicly available data.
They are not buy/sell recommendations. Please consult a financial advisor before investing.
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully.